Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Johnson and Johnson delivers another excellent quarter

This article was originally published in Clinica

Executive Summary

US healthcare conglomerate Johnson & Johnson has reported another strong quarter in the three months to September. Fuelled by the Palmaz-Schatz coronary stent, professional products sales rose 27% to $1,679 million in the third quarter, outperforming J&J's consumer product and pharmaceutical divisions. Kurt Kruger, an analyst at brokers Hambrecht & Quist, estimates the stent's sales will reach $450 million this year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093757

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel